Senti Biosciences to effect 1-for-10 reverse stock split for Nasdaq compliance

seekingalpha07-16

Biotechnology company Senti Biosciences (NASDAQ:SNTI) said on Tuesday that it will effect a 1-for-10 reverse stock split to regain compliance with Nasdaq rules. The company's board approved a 1-for-10...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2451691369?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1293330840/image_1293330840.jpg","is_english":true,"pubTime":"2024-07-16 20:50","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2451691369","market":"sh","top_or_hot":-1,"title":"Senti Biosciences to effect 1-for-10 reverse stock split for Nasdaq compliance","media":"seekingalpha","content":"<div>\n<p>Biotechnology company Senti Biosciences (NASDAQ:SNTI) said on Tuesday that it will effect a 1-for-10 reverse stock split to regain compliance with Nasdaq rules. The company's board approved a 1-for-10...</p>\n\n<a href=\"https://seekingalpha.com/news/4124571-senti-biosciences-to-effect-1-for-10-reverse-stock-split-for-nasdaq-compliance\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Senti Biosciences to effect 1-for-10 reverse stock split for Nasdaq compliance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSenti Biosciences to effect 1-for-10 reverse stock split for Nasdaq compliance\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-16 20:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4124571-senti-biosciences-to-effect-1-for-10-reverse-stock-split-for-nasdaq-compliance><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biotechnology company Senti Biosciences (NASDAQ:SNTI) said on Tuesday that it will effect a 1-for-10 reverse stock split to regain compliance with Nasdaq rules. The company's board approved a 1-for-10...</p>\n\n<a href=\"https://seekingalpha.com/news/4124571-senti-biosciences-to-effect-1-for-10-reverse-stock-split-for-nasdaq-compliance\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NDAQ","symbol_name":"纳斯达克OMX交易所","start_time":0,"source_url":"https://seekingalpha.com/news/4124571-senti-biosciences-to-effect-1-for-10-reverse-stock-split-for-nasdaq-compliance","article_id":"2451691369","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1293330840/image_1293330840.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2451691369","pubTimestamp":1721134217,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Biotechnology company Senti Biosciences  said on Tuesday that it will effect a 1-for-10 reverse stock split to regain compliance with Nasdaq rules. The company's board approved a 1-for-10 reverse stock split, effective July 1711:59 PM EDT. SNTI shares were trading-0.03%pre-market. The new CUSIP number will be 81726A209. The reverse stock split will reduce the company's outstanding shares to ~4.6M from ~45.8M. The move comes in the wake of Nasdaq notifying Senti Bio of non-compliance with the stock exchange's minimum bid price requirement. Source: Press Release","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"NDAQ":"纳斯达克OMX交易所","QID":"纳指两倍做空ETF","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","PSQ":"纳指反向ETF","BK4588":"碎股","TQQQ":"纳指三倍做多ETF","BK4139":"生物科技","BK4539":"次新股","BK4112":"金融交易所和数据","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","QLD":"纳指两倍做多ETF",".IXIC":"NASDAQ Composite","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","BK4585":"ETF&股票定投概念","SQQQ":"纳指三倍做空ETF","SNTI":"Senti Biosciences, Inc."},"translate_title":"Senti Biosciences将进行10股1股的反向股票分割，以符合纳斯达克法规","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SNTI":1,"NQmain":1,"NDAQ":1,".IXIC":1,"TQQQ":0.6,"SQQQ":0.6,"QLD":0.6,"QID":0.6,"PSQ":0.6,"MNQmain":0.6},"content_text":"Biotechnology company Senti Biosciences (NASDAQ:SNTI) said on Tuesday that it will effect a 1-for-10 reverse stock split to regain compliance with Nasdaq rules. The company's board approved a 1-for-10 reverse stock split, effective July 17 11:59 PM EDT. SNTI shares were trading -0.03% pre-market. The new CUSIP number will be 81726A209. The reverse stock split will reduce the company's outstanding shares to ~4.6M from ~45.8M. The move comes in the wake of Nasdaq notifying Senti Bio of non-compliance with the stock exchange's minimum bid price requirement. Source: Press Release","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"Policy And Regulatory","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2451691369"}